Patents by Inventor Richard Johnsson

Richard Johnsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11919921
    Abstract: An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
    Type: Grant
    Filed: May 19, 2022
    Date of Patent: March 5, 2024
    Assignee: GALECTO BIOTECH AB
    Inventors: Thomas Brimert, Richard Johnsson, Hakon Leffler, Ulf Nilsson, Fredrik Zetterberg
  • Publication number: 20230391841
    Abstract: The present disclosure relates to the field of unconventional neurotrophic factors and to the field of treating degenerative, chronic or progressive diseases and disorders, and monogenic hereditary diseases having ER stress as a pathogenic compound. More particularly the disclosure relates to modified peptides, particularly macrocyclic peptides. The disclosure also relates to pharmaceutical compositions comprising said peptides. Further, the disclosure also relates to said peptides, and pharmaceutical compositions for use as a medicament and in the treatment of degenerative, chronic or progressive diseases and disorders, and monogenic hereditary diseases having ER stress as a pathogenic compound as well as to methods for treating said diseases and disorders.
    Type: Application
    Filed: December 17, 2020
    Publication date: December 7, 2023
    Inventors: Henri HUTTUNEN, Arnab BHATTACHARJEE, Richard JOHNSSON, Maria VOLKOVA, Natalia KULESSKAYA
  • Publication number: 20220289783
    Abstract: An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
    Type: Application
    Filed: May 19, 2022
    Publication date: September 15, 2022
    Applicant: Galecto Biotech AB
    Inventors: Thomas BRIMERT, Richard JOHNSSON, Hakon LEFFLER, Ulf NILSSON, Fredrik ZETTERBERG
  • Patent number: 11377464
    Abstract: An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
    Type: Grant
    Filed: September 11, 2020
    Date of Patent: July 5, 2022
    Assignee: Galecto Biotech AB
    Inventors: Thomas Brimert, Richard Johnsson, Hakon Leffler, Ulf Nilsson, Fredrik Zetterberg
  • Publication number: 20200407391
    Abstract: An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
    Type: Application
    Filed: September 11, 2020
    Publication date: December 31, 2020
    Applicant: Galecto Biotech AB
    Inventors: Thomas BRIMERT, Richard JOHNSSON, Hakon LEFFLER, Ulf NILSSON, Fredrik ZETTERBERG
  • Patent number: 10774102
    Abstract: An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
    Type: Grant
    Filed: January 28, 2016
    Date of Patent: September 15, 2020
    Assignee: Galecto Biotech AB
    Inventors: Thomas Brimert, Richard Johnsson, Hakon Leffler, Ulf Nilsson, Fredrik Zetterberg
  • Patent number: 10730902
    Abstract: The present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore, the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: August 4, 2020
    Assignee: GALECTO BIOTECH AB
    Inventors: Fredrik Zetterberg, Ulf Nilsson, Hakon Leffler, Anders Pedersen, Hans Schambye, Thomas Brimert, Richard Johnsson
  • Patent number: 10526360
    Abstract: An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: January 7, 2020
    Assignee: Galecto Biotech AB
    Inventors: Thomas Brimert, Richard Johnsson, Hakon Leffler, Ulf Nilsson, Fredrik Zetterberg
  • Publication number: 20190359643
    Abstract: An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
    Type: Application
    Filed: August 13, 2019
    Publication date: November 28, 2019
    Applicant: Galecto Biotech AB
    Inventors: Thomas BRIMERT, Richard JOHNSSON, Hakon LEFFLER, Ulf NILSSON, Fredrik ZETTERBERG
  • Patent number: 10464964
    Abstract: An Embodiment of the invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
    Type: Grant
    Filed: January 14, 2016
    Date of Patent: November 5, 2019
    Assignee: Galecto Biotech AB
    Inventors: Fredrik Zetterberg, Ulf Nilsson, Hakon Leffler, Thomas Brimert, Richard Johnsson, Priya Verma
  • Publication number: 20180327440
    Abstract: The present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore, the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
    Type: Application
    Filed: November 8, 2016
    Publication date: November 15, 2018
    Applicant: GALECTO BIOTECH AB
    Inventors: Fredrik ZETTERBERG, Ulf NILSSON, Hakon LEFFLER, Anders PEDERSEN, Hans SCHAMBYE, Thomas BRIMERT, Richard JOHNSSON
  • Publication number: 20170349619
    Abstract: An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
    Type: Application
    Filed: January 28, 2016
    Publication date: December 7, 2017
    Applicant: Galecto Biotech AB
    Inventors: Thomas BRIMERT, Richard JOHNSSON, Hakon LEFFLER, Ulf NILSSON, Fredrik ZETTERBERG
  • Publication number: 20170334940
    Abstract: An Embodiment of the invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
    Type: Application
    Filed: January 14, 2016
    Publication date: November 23, 2017
    Applicant: Galecto Biotech AB
    Inventors: Fredrik ZETTERBERG, Ulf NILSSON, Hakon LEFFLER, Thomas BRIMERT, Richard JOHNSSON, Priya VERMA
  • Patent number: 8364917
    Abstract: A method for replicating a deduplicated storage system is disclosed. A stream of data is stored on an originator deduplicating system by storing a plurality of deduplicated segments and information on how to reconstruct the stream of data. The originator deduplicating system is replicated on a replica system by sending a copy of the plurality of deduplicated segments and information on how to reconstruct the stream of data to the replica system. A first portion of the deduplicated segments stored on the originator deduplicating system that is corrupted is identified. A copy of the first portion of the deduplicated segments is requested to be sent by the replica system to the originator deduplicating system.
    Type: Grant
    Filed: April 2, 2012
    Date of Patent: January 29, 2013
    Assignee: EMC Corporation
    Inventors: Allan J. Bricker, Richard Johnsson, Greg Wade
  • Publication number: 20120191931
    Abstract: A method for replicating a deduplicated storage system is disclosed. A stream of data is stored on an originator deduplicating system by storing a plurality of deduplicated segments and information on how to reconstruct the stream of data. The originator deduplicating system is replicated on a replica system by sending a copy of the plurality of deduplicated segments and information on how to reconstruct the stream of data to the replica system. A first portion of the deduplicated segments stored on the originator deduplicating system that is corrupted is identified. A copy of the first portion of the deduplicated segments is requested to be sent by the replica system to the originator deduplicating system.
    Type: Application
    Filed: April 2, 2012
    Publication date: July 26, 2012
    Applicants: EMC CORPORATION
    Inventors: Allan J. Bricker, Richard Johnsson, Greg Wade
  • Patent number: 8176277
    Abstract: A method of replicating a deduplicated storage system is disclosed. The method comprises storing a stream of data on an originator deduplicating system by storing deduplicated segments and information on how to reconstruct the stream of data. The method further comprises replicating the originator deduplicating system by receiving a copy of the deduplicated segments, information regarding containers for the deduplicated segments, and information on how to reconstruct the stream of data transferred from the originator deduplicating system to the replica system.
    Type: Grant
    Filed: August 24, 2011
    Date of Patent: May 8, 2012
    Assignee: EMC Corporation
    Inventors: Allan J. Bricker, Richard Johnsson, Greg Wade
  • Publication number: 20110307441
    Abstract: A method of replicating a deduplicated storage system is disclosed. The method comprises storing a stream of data on an originator deduplicating system by storing deduplicated segments and information on how to reconstruct the stream of data. The method further comprises replicating the originator deduplicating system by receiving a copy of the deduplicated segments, information regarding containers for the deduplicated segments, and information on how to reconstruct the stream of data transferred from the originator deduplicating system to the replica system.
    Type: Application
    Filed: August 24, 2011
    Publication date: December 15, 2011
    Applicants: EMC CORPORATION
    Inventors: Allan J. Bricker, Richard Johnsson, Greg Wade
  • Patent number: 8028138
    Abstract: A method of replicating a deduplicated storage system is disclosed. The method comprises requesting the state of a replica system. The method further comprises sending a container to the replica system and sending a file system log record to the replica system.
    Type: Grant
    Filed: July 24, 2009
    Date of Patent: September 27, 2011
    Assignee: EMC Corporation
    Inventors: Allan J. Bricker, Richard Johnsson, Greg Wade
  • Patent number: 7747581
    Abstract: A network file system-based data storage system that converts random I/O requests into a piecewise sequential data structure to facilitate variable length data segment redundancy identification and elimination. For one embodiment of the invention a stateless network file system is employed. For one such embodiment, that provides multiple-client access to stored data, multiple Writes are buffered and then broken into variable length data segments. Redundant segment elimination is then effected. One embodiment of the invention allows sharing of the variable length data segments among files.
    Type: Grant
    Filed: April 19, 2007
    Date of Patent: June 29, 2010
    Assignee: EMC Corporation
    Inventors: Kai Li, R. Hugo Patterson, Ming Benjamin Zhu, Allan Bricker, Richard Johnsson, Sazzala Reddy, Jeffery Zabarsky
  • Patent number: 7689633
    Abstract: A network file system-based data storage system that converts random I/O requests into a piecewise sequential data structure to facilitate variable length data segment redundancy identification and elimination. For one embodiment of the invention a stateless network file system is employed. For one such embodiment, that provides multiple-client access to stored data, multiple Writes are buffered and then broken into variable length data segments. Redundant segment elimination is then effected. One embodiment of the invention allows sharing of the variable length data segments among files.
    Type: Grant
    Filed: September 15, 2004
    Date of Patent: March 30, 2010
    Assignee: Data Domain, Inc.
    Inventors: Kai Li, R. Hugo Patterson, Ming Benjamin Zhu, Allan Bricker, Richard Johnsson, Sazzala Reddy, Jeffery Zabarsky